BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27908443)

  • 21. Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.
    Yang B; Jhun BW; Shin SH; Jeong BH; Um SW; Zo JI; Lee HY; Sohn I; Kim H; Kwon OJ; Lee K
    PLoS One; 2018; 13(7):e0201242. PubMed ID: 30063725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model of malignant risk prediction for solitary pulmonary nodules on
    Yu M; Wang Z; Yang G; Cheng Y
    Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of pulmonary nodules detected on abdominal CT in pediatric patients.
    Breen M; Zurakowski D; Lee EY
    Pediatr Radiol; 2015 Nov; 45(12):1753-60. PubMed ID: 26164441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
    Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
    Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.
    Ruppert AM; Lerolle U; Carette MF; Lavole A; Khalil A; Bazelly B; Antoine M; Cadranel J; Milleron B
    Lung Cancer; 2011 Nov; 74(2):233-8. PubMed ID: 21511355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules.
    Mehta HJ; Ravenel JG; Shaftman SR; Tanner NT; Paoletti L; Taylor KK; Tammemagi MC; Gomez M; Nietert PJ; Gould MK; Silvestri GA
    Chest; 2014 Mar; 145(3):464-472. PubMed ID: 23949741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of malignancy of pulmonary nodules at CT scans: Effect of computer-aided diagnosis on diagnostic performance of radiologists.
    Liu J; Zhao L; Han X; Ji H; Liu L; He W
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):216-221. PubMed ID: 32757455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Communication About the Probability of Cancer in Indeterminate Pulmonary Nodules.
    Maiga AW; Deppen SA; Massion PP; Callaway-Lane C; Pinkerman R; Dittus RS; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):353-357. PubMed ID: 29261826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.
    Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES
    Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Radiomics in Predicting the Malignancy of Pulmonary Nodules in Different Sizes.
    Xu Y; Lu L; E LN; Lian W; Yang H; Schwartz LH; Yang ZH; Zhao B
    AJR Am J Roentgenol; 2019 Dec; 213(6):1213-1220. PubMed ID: 31557054
    [No Abstract]   [Full Text] [Related]  

  • 32. Validation of prediction models for risk stratification of incidentally detected pulmonary subsolid nodules: a retrospective cohort study in a Korean tertiary medical centre.
    Kim H; Park CM; Jeon S; Lee JH; Ahn SY; Yoo RE; Lim HJ; Park J; Lim WH; Hwang EJ; Lee SM; Goo JM
    BMJ Open; 2018 May; 8(5):e019996. PubMed ID: 29794091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of risk models for management of pulmonary nodules].
    Prosch H; Baltzer P
    Radiologe; 2014 May; 54(5):449-54. PubMed ID: 24737068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.
    Gould MK; Ananth L; Barnett PG;
    Chest; 2007 Feb; 131(2):383-8. PubMed ID: 17296637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.
    Godfrey CM; Shipe ME; Welty VF; Maiga AW; Aldrich MC; Montgomery C; Crockett J; Vaszar LT; Regis S; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Maldonado F; Blume JD; Deppen SA; Grogan EL
    Chest; 2023 Nov; 164(5):1305-1314. PubMed ID: 37421973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Three Dimensional Volumetric Analysis of Solid Pulmonary Nodules on Chest CT: 
Cancer Risk Assessment].
    Li M; Han R; Song W; Wang X; Guo F; Su D; Yu T; Wang Y
    Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):279-85. PubMed ID: 27215456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of a mathematical prediction model to evaluate the probability of malignancy or benign in patients with solitary pulmonary nodules].
    Li Y; Chen KZ; Sui XZ; Bu L; Zhou ZL; Yang F; Liu YG; Zhao H; Li JF; Liu J; Jiang GH; Wang J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):450-4. PubMed ID: 21681281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.